Abirakast - 250 Mg Abiraterone Acetate, 120 Tablets | Hormonal Therapy For Prostate Cancer, Dry Enzyme, Normal Smell, 3-year Shelf Life

Abirakast 250 mg is part of a class of hormonal therapies used to treat prostate cancer in adults. Abirakast 250 mg (abiraterone acetate) is used for prostate cancer patients who have failed to respond to conventional chemotherapy alternatives. In addition, it is indicated in asymptomatic patients who have failed to respond to conventional hormonal therapies and have not received chemotherapy. Abirakast 250 mg (Abiraterone acetate) inhibits the production of (a male hormone) that is important for cancer cell development. It works by inhibiting stimulating proteins (the CYP17A1 enzyme), lowering the risk of cancer in the body. Abirakast 250 mg (abiraterone acetate) is taken orally, with or without food.